 

UUID:778F288C-F5ED-4A05-BFDE-36063F43EG22
TCGA-CC-ASUD-alA—PR REdTlilitEd

lllHllHllllllllllllllllllllllllllllllllllllllllllllllllll

Ill
IllllllllllllllllHlllllllllllllllllllll
I“ lllllllllll‘l 1Illillllll{llmmllllllll llll I llllllll ll llllllllll I II III '

Clinical Case Report 9,50“ .1650 ,5 «3 N6
(For Collection of Seneerous Tissue) / ,8/ 70 /3

«it
{0" . t m M [M
W 3270/5

45433.: ail/ha,- » N65

 

 

I personally informed this patient that a specimen(s) would be collected to be used for research
purposes. I reviewed the RESEARCH SUBJECT INFORMATION AND CONSENT

FORM with the patient and answered any questions the patient had. The patient then signed the
consent form as a free and voluntary act. A copy of this informed consent document will be retained at

our institution.

Fathedfl’hysiciadoristudy Coordinator _. / Signature Date

 

nautical Informationl

GENERAL TION
Dated Blrth._

[3 Single )0 Married "~‘ F

/ Gender D Divorced D Widow Blood Pressure React Rate
Male E3 Female
f,

_ HISTORY OF PRESENT ILLNESS
Chief Complaints: Abzﬁlw McLQ pat/1% / ﬁgs/U 94.

Symptoms: bu Quip-MM ) W “WM (/0595,
Clinical Findings:

 

 

 

 

 

 

Performance Scale (Karnofsky Score):
:3 100 Asymptomatic 80-90 Symptomatic but Fully Ambulatory s3 60~70 Symptomatic, in bed less than 50% of day
a 40-50 S mptomatic, in bed more than 50% of day, but not bed ridden a 20-30 Bed Ridden

 

 

 

CURRENT MEDICATIONS

 

PAST MEDICAL HISTORY
Disorder

Date

 

 

 

 

 

 

()B/GYN HISTORY
Menopausal Status Date of First Menses # of Pregnancies
c3 Pro-menopausal
D Peri~Menopausal Date of Last Menses # of Live Births
D Postmenopausal

 

 

Birth Control: Cl Condom Cl Oral Contraceptive
D Other:

a IUD u Hormone Replacement

Therapy:

 

 

 

 

SOCIAL HISTORY
Hazards:

Current
YES [3 NO
Alcohol
Current
Cl N0

Current Status
[3 YES NO

FAMILY MEDICAL HISTORY

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

LAB DATA

Test Result I Date I Test Result Date
HIV ‘jZlNegative {3 Positive“ CEA 0 Negative a Positive:

Hep B y) Negative E3 Positive: CA 1533 El Negative {3 Positive:

Hep C QNegative Ct Positive: CA 19-9 C3 Negative El Positive:
AFP Ci Negative {:3 Positive: PSA D Negative Cl Positive:

0th“: [:1 Negative :3 Positive: Other: 0 Negative [3 Positive:

B/T Cell Markers:

 

 

DIAGNOSTIC STUDIES
Results

Ultrasound
X—Ra
CT

MRI
B

CLINICAL DIAGNOSIS

' V , 2
Location of Distant

Clinical Date of
“r N a; M 0 Stage: in ﬁr

 

 

[Treatment Informatiorij
SURGICAL TREATMENT

‘ /
Prime
Detailed

Extension of Tumor

L Nodes
Lotatlon of L Nodes
Palpable, Non—Dissected Lymph Nodes

Dissected Lymph Nodes
Distant Metastasis

Detailed Location

T N M

NEOADJUVENT THERAPY
Dose Route

 

Pathology Form

 

LSpecimen Information!

 

 

 

 

 

 

 

 

 

 

 

Collected by: __ Date; Time;

Preserved by: w Date Time:~
SPECIMEN TYPE (# of samples provided)

Frozen Paraffin Block Blood/SerumfPlasma Slide
Diseased Normal Diseased Normal Diseased Normal Diseased Normal
0 4 0 4 0
Time to LN2 Time to Formalin Time to LNZ
1’4 min / 2 min min

 

 

 

 

 

PATHOLOGICAL DESCRIPTION

Tumor
Size Extension of Tumor Distance to NAT

x x ”cm * cm

L Nodes
# # Metastaslzed

Distant Metastasis
Detailed

 

Consolidated Pathology Diagnosis
ID#:

Cellular Differentiation:

Nuclear
Nudeosis

Nuclear Grade:

0,7 7))7 037 , Dyll .r / L

 

 

 

 

 

r
{Final Pathology Renard
Histological Diagnosis: WW5? gjﬂiZQ/ﬂ. @112 UMaGrade: 2
519%)?! 4;:
Comments: 0‘ (I

 

 

 

h Date

 

Director, Research Pathology

 

